Compare IQV & STLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | STLD |
|---|---|---|
| Founded | 1982 | 1993 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6B | 38.9B |
| IPO Year | 2013 | 1996 |
| Metric | IQV | STLD |
|---|---|---|
| Price | $203.92 | $228.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $227.13 | $210.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.3M |
| Earning Date | 05-05-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | 1.61 | ★ 2.78 |
| Revenue | $9,739,000,000.00 | ★ $22,260,774,000.00 |
| Revenue This Year | $6.77 | $17.86 |
| Revenue Next Year | $5.89 | $2.86 |
| P/E Ratio | $129.54 | ★ $82.63 |
| Revenue Growth | ★ 41.60 | 20.92 |
| 52 Week Low | $154.50 | $119.89 |
| 52 Week High | $247.05 | $288.74 |
| Indicator | IQV | STLD |
|---|---|---|
| Relative Strength Index (RSI) | 66.57 | 39.95 |
| Support Level | $159.91 | $219.03 |
| Resistance Level | $209.48 | $243.73 |
| Average True Range (ATR) | 7.02 | 8.40 |
| MACD | 2.45 | -3.72 |
| Stochastic Oscillator | 84.77 | 21.96 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Steel Dynamics Inc operates as a domestic steel producer and metal recycler in the United States. The company's product portfolio comprises hot rolled sheet, hot rolled plate, painted sheet products, cold rolled sheet, and others. Its reportable segments are steel operations, metals recycling operations, steel fabrication operations, and aluminum operations. Maximum revenue is generated from its steel operations segment, which consists of manufacturing various steel products and numerous coating operations. Its primary sources of revenue are currently from the manufacture and sale of steel products, the processing and sale of recycled ferrous and nonferrous metals, and the fabrication and sale of steel joists and deck products.